新云社 update: Isomorphic Labs, Alphabet’s AI drug-discovery unit led by Nobel laureate Demis Hassabis, has closed a $5 billion Series C round co-led by Greenoaks and Sequoia Capital. Alphabet contributed substantial funding, with new investors including a16z and existing backers Thrive Capital, MGX, GV, CapitalG, Temasek and the UK Sovereign AI Fund participating. The company will use the proceeds to advance its foundational simulation models, scale internal and partnered drug programs, and build global AI-driven bioengineering infrastructure.
Alphabet’s Isomorphic Labs raises $5B Series C led by Greenoaks, Sequoia
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
2h ago
Tencent Hunyuan’s Yao Shunyu says next-gen model to scale up significantly
2h ago
SoftBank’s Son Considered $1T Bid for SK Hynix, No Longer Active
2h ago
Anthropic researcher claims Claude helped prove Riemann Hypothesis
2h ago
Trump calls for Jensen Huang’s return to Nvidia after China trip
2h ago
CertiK and Columbia Researchers Complete First Production-Grade Formal Verification of DeepSeek, FlashAttention AI Kernels
2h ago
Zhejiang University Team Achieves World’s First QRAM on Superconducting Chip




